Talis Biomedical Corporation Faces Stock Sell-Off Amidst Restructuring and Bankruptcy Concerns
The shares of Talis Biomedical Corporation (NASDAQ: TLIS) have experienced a significant sell-off in recent trading sessions, plummeting by 49% to $4.58. This drastic decrease has raised concerns among investors and has...
Aug 8, 2024
• Laboratory Analytical Instruments Industry
Stocks on the Move
Wednesdays Stock Advice Talis Biomedical Wednesday
